Mission Pharmacal Company-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Mission Pharmacal Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013445
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mission Pharmacal Company (Mission Pharmacal) is a pharmaceutical company, which develops, manufactures and markets prescription, over-the-counter, and dietary supplement products. It offers products for conditions related to women’s health, urology, pediatrics, and dermatology, among others. The company also offers contract manufacturing services. Mission Pharmacal has manufacturing and packaging capabilities to produce products in various forms such as powders, tablets, solutions, creams, lotions, gels and suspensions. It operates in the US and international markets through its distribution and sales network. The company has a manufacturing facility in Texas, with capabilities such as warehousing, manufacturing, and research and development. Mission Pharmacal is headquartered in San Antonio, Texas, the US.

Mission Pharmacal Company – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mission Pharmacal Company, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Mission Pharmacal Company, Medical Devices Deals, 2011 to YTD 2017 9
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Espada Dermatology Acquires GlyDerm from Lautus Pharma 11
Mission Pharmacal Acquires Eletone Cream From Ferndale Healthcare 12
Partnerships 13
DARA BioSciences Enters into Co-Promotion Agreement with Mission Pharmacal 13
Meda Enters Promotion Agreement With Mission Pharmacal For Elestrin 14
Licensing Agreements 15
Retrophin Amends Licensing Agreement with Mission Pharmacal for Thiola 15
EffRx Pharma Enters Into Licensing Agreement With Mission Pharmacal For Binosto 16
Acquisition 17
Mission Pharmacal Acquires ProSolus Pharma 17
Mission Pharmacal Company – Key Competitors 18
Mission Pharmacal Company – Key Employees 19
Mission Pharmacal Company – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Product News 22
May 03, 2016: Mission Pharmacal’s Lycelle Head Lice Removal Kit Is Now Available In Pharmacies 22
02/10/2016: Statement on Imprimis Pharmaceuticals Announcement Regarding Thiola 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Key Facts 2
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mission Pharmacal Company, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mission Pharmacal Company, Deals By Therapy Area, 2011 to YTD 2017 8
Mission Pharmacal Company, Medical Devices Deals, 2011 to YTD 2017 9
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Espada Dermatology Acquires GlyDerm from Lautus Pharma 11
Mission Pharmacal Acquires Eletone Cream From Ferndale Healthcare 12
DARA BioSciences Enters into Co-Promotion Agreement with Mission Pharmacal 13
Meda Enters Promotion Agreement With Mission Pharmacal For Elestrin 14
Retrophin Amends Licensing Agreement with Mission Pharmacal for Thiola 15
EffRx Pharma Enters Into Licensing Agreement With Mission Pharmacal For Binosto 16
Mission Pharmacal Acquires ProSolus Pharma 17
Mission Pharmacal Company, Key Competitors 18
Mission Pharmacal Company, Key Employees 19
Mission Pharmacal Company, Other Locations 20
Mission Pharmacal Company, Subsidiaries 20

★海外企業調査レポート[Mission Pharmacal Company-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Episurf Medical AB (EPIS B):医療機器:M&Aディール及び事業提携情報
    Summary Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. The company offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, E …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CytoBioscience Inc:医療機器:M&Aディール及び事業提携情報
    Summary CytoBioscience Inc (CytoBioscience), formerly Cytocentrics Bioscience GmbH is a biotechnology company that manufactures of medical devices for ion channel research. The company’s products include CytoPatch instrumentations. It provides services such as adult human heart, expression systems, …
  • Genzyme Corp:医療機器:M&Aディール及び事業提携情報
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosi …
  • GC Pharma (006280):企業の財務・戦略的SWOT分析
    GC Pharma (006280) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • iKang Healthcare Group Inc:企業の戦略・SWOT・財務情報
    iKang Healthcare Group Inc - Strategy, SWOT and Corporate Finance Report Summary iKang Healthcare Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Inner Mongolia Yili Industrial Group Co., Ltd.:戦略・SWOT・企業財務分析
    Inner Mongolia Yili Industrial Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Inner Mongolia Yili Industrial Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Hemisphere Energy Corp (HME):企業の財務・戦略的SWOT分析
    Summary Hemisphere Energy Corp (Hemisphere), formerly Northern Hemisphere Development Corp is an oil and gas company that offers development of oil production reserves. The company offers strategic acquisitions and farm-ins that provide low-risk drilling opportunities. Its operations include heavy o …
  • Entercom Communications Corp (ETM):企業の財務・戦略的SWOT分析
    Summary Entercom Communications Corp (Entercom) is a provider of media and entertainment services. The company offers radio broadcasting programs. It owns and operates radio stations in various formats, including classic rocks, sports, news, talk, adult contemporary, alternative and country and othe …
  • Fagron NV (FAGR):製薬・医療:M&Aディール及び事業提携情報
    Summary Fagron NV (Fagron), formerly Arseus NV is a pharmaceutical compounding solution provider. The company offers products such as raw materials, extracts and tinctures, flammable products, anesthesia, ointment bases, syrups, suspension media, triturations, phyto pharmaflore, medispend, capsicard …
  • InnaVirVax SA-製薬・医療分野:企業M&A・提携分析
    Summary InnaVirVax SA (InnaVirVax) is a biopharmaceutical company which discovers and develops products for the treatment of HIV/AIDS infection pathologically and novel cancer therapies. The company's pipeline product portfolio comprise DIAG-3S, an AIDS prognostic test; VAC-3S, an HIV AIDs therapeut …
  • Ctrip.Com International Ltd
    Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report Summary Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Dataprep Holdings Bhd (DATAPRP):企業の財務・戦略的SWOT分析
    Dataprep Holdings Bhd (DATAPRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Summit Exploration and Production Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Summit Exploration and Production Ltd (Summit), a subsidiary of Sumitomo Corp, is an independent upstream oil and gas company that explores, develops and produces oil and gas assets. The company holds operator interests for exploration in the UK North Sea. It has two production assets such a …
  • EaglePicher Technologies LLC:企業の戦略的SWOT分析
    EaglePicher Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Credit Saison Co., Ltd.:企業の戦略・SWOT・財務分析
    Credit Saison Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Credit Saison Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Borders & Southern Petroleum plc (BOR):企業の財務・戦略的SWOT分析
    Summary Borders & Southern Petroleum Plc (Borders & Southern Petroleum) is an oil and gas company that offers exploration and development of hydrocarbons. The company holds interests in three production licenses in the Falkland Islands located south-east of the Islands. Its production licenses provi …
  • SpringWorks Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary SpringWorks Therapeutics LLC (SpringWorks Therapeutics) is a drug development company that develops therapeutic medicines for various diseases. The company’s pipeline products include Nirogacestat, MEK ½ Inhibitor, Senicapoc and FAAH Inhibitor. Its Nirogacestat is a gamma secretase inhibitor …
  • Westar Energy Inc.:企業の戦略・SWOT・財務情報
    Westar Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Westar Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sealed Air Corporation:企業の戦略・SWOT・財務情報
    Sealed Air Corporation - Strategy, SWOT and Corporate Finance Report Summary Sealed Air Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆